Thank you, Peter. Welcome everyone. I hope you're all safe and healthy. And I will first review the first quarter financial results and then make some comments on the second quarter of 2020. I would also provide more detail around measures we are taking with regards to cash management. Net sales came in at €2.4 billion below our original guidance of €3.1 billion to €3.3 billion, which was primarily related to COVID-19 impact. Net system sales of €1.6 billion was again heavily weighted toward Logic at 73% with the remaining 27% from Memory, clearly showing the continued strength of Logic business. We actually shipped four EUV systems in Q1, but were only able to recognize revenue on two systems, which I will explain in more detail later. Installed base management sales for the quarter came in at €857 million. This was around €100 million lower than guided due to lack of access to machine time as well as a delay in acceptance of upgrades. We expect these upgrades to translate to revenue in Q2. Let me provide a bit more detail on the items that occurred in the quarter that resulted in a system revenue shift of around €700 million, consisting of a Deep UV related revenue shift over €200 million and EUV related revenue shift of over €500 million, primarily related to COVID-19 impact. First, we experienced some delays in Deep UV shipments to customers in Wuhan, China, as well as other customers due to operational and travel restrictions regarding COVID-19. We are working with our customers to prepare for these shipments in the next quarters. Second, we experienced some issues in our supply chain as a result of a temporary disruption from EUV component suppliers that encountered operational restrictions due to COVID-19 regulations. These supply chain issues have been solved for now. Also, we experienced longer-than initially planned EUV cycle times for the first NXE:3400C models in final configuration, primarily driven by the complex deployment of inline tin refill as part of the modular vessel. Cycle time related to this aspect is now being reduced every week, and we are on track to achieving the aspired cycle time reduction envisaged for the end of this year. As you know, this is an important element in achieving the capability of 45 to 50 EUV tools in 2021 and beyond. As a result of the longer-than-expected cycle times as well as COVID-19 related supply issues, we saw some delays in EUV shipments for the quarter resulting in fewer system shipments than originally planned. Third, due to concerns around the continued ability to ship systems in the current circumstances, some customers have asked us to expedite the delivery of EUV systems in the quarter by shipping the systems before the normal factory acceptance tests. The implication of this is a delay in our revenue recognition as final acceptance will now take place after a successful installation at the customer sites. We expect the revenue that we were not able to recognize for Q1 as a result of the issues listed above to shift to Q2 and Q3 of this year. Gross margin for the quarter was 45.1%, also below our original guidance, primarily due to a combination of delayed field upgrades, as well as delayed DPV systems revenue related to COVID-19 impact. Overall, operating expenses came within guidance with R&D expenses at €544 million and SG&A expenses at €130 million. Turning to the balance sheet, €507 million worth of shares were repurchased in Q1. We ended last quarter with cash, cash equivalents and short-term investments at a level of €4.1 billion. Moving to the order book, Q1 system bookings came in at a strong €3.1 billion, including €1.5 billion from 11 EUV systems. Logic order intake were 66% of the total value with the remaining 34% for memory, again reflecting the continued strong logic demand for leading edge lithography for this year and next year, but also indicating a recovery of the demand for memory. Net income in Q1 was €391 million, representing 16% of net sales and resulting in an EPS of €0.93. With that, I would like to make some comments on Q2 of 2020. As Peter mentioned, we have not seen a reduction in demand this year and we continued to see a strong order intake, up around 28% from Q4. Based on current plans without any COVID interruption, Q2 can be a strong shipment quarter with revenue up potentially over 50% from Q1 and a significant improvement of gross margin. We are still planning to execute to current plan. However, due to significant uncertainty in this COVID-19 environment, we decided it is prudent to refrain from giving formal guidance for Q2. Finally, on cash management. Although, we have a very healthy balance sheet, as well as flexibility in our cost structure, we like many of our peers and customers, are dependent on the short and longer-term implications of the COVID-19 outbreak. Due to these uncertainties, we feel it is prudent to preserve cash should the situation continue for an extended period of time, not just for our own operations but also in order to be able to support our suppliers as best we can in these extraordinary circumstances. We have decided not to execute any share buybacks in Q2 2020. This decision follows the pause and the execution of the program in the first quarter, after having already performed share buybacks under the new program for an amount of approximately €507 million. The previously announced three year share buyback program of up to €6 billion to be executed in the 2020, 2022 timeframe is still in place. We have also implemented measures to limit our growth in the workforce. Non-business critical vacancies have been put on hold. We continue to hire for business critical positions. This way, our workforce will grow less than originally planned this year. We are also postponing any non-business critical OpEx and CapEx. However, we will continue to invest in the development of future technology roadmaps, including High-NA at an unadjusted pace in order to allow our customers the continuation of their roadmaps once the situation has been normalized. As communicated last quarter, ASML has submitted a proposal at its 2020 Annual General Meeting of shareholders to declare a total dividend for 2019 of €2.40 per ordinary share. Recognizing the interim dividend of €1.05 paid in November 2019, this leads to a final dividend payment of €1.35 to be paid in the second quarter. This is a 14% increase compared to the 2018 dividend. The 2020 Annual General Meeting of shareholders will take place on April 22nd in Veldhoven. With that, I'd like to turn the call back over to Peter.